PROTXX, Silicon Valley and Calgary-based precision medicine technology pioneer, and AltaML, Alberta-based artificial intelligence (AI) and machine learning (ML) product developer, joined hands to expand the data analytics capabilities of the PROTXX precision healthcare platform. The step taken will support automated diagnoses of neurodegenerative medical conditions.
The PROTXX precision healthcare platform combines wearable sensor and machine learning technologies to replace cumbersome and costly surgical equipment and time-consuming research methods for a variety of neurodegenerative medical conditions in which patients suffer from impairments to multiple physiological systems. PROTXX resolves the difficult problem of detecting and quantifying these various impairments, disrupting diagnosis, and treatment with easy-to-use, low-cost, accurate patient evaluations.
Cory Janssen, Co-Founder and CEO of AltaML, said, “Our initial work with PROTXX will focus on developing solutions that address two major ML challenges in digital healthcare: classifying medical conditions using relatively small data sets and enabling visualization and explanation of ML diagnoses based on intuitive physiological features. The PROTXX sensors generate data well suited for ML, and we are excited to have this opportunity to accelerate time-to-market for PROTXX solutions that will reduce the cost and time required to make accurate clinical diagnoses and quantify patient responses to treatment and rehabilitation.”
AltaML is building a range of ML-powered tech applications for the future across various industries like healthcare.
PROTXX announced earlier this year the establishment of the PROTXX Medical Ltd subsidiary in Alberta to support product creation and pilot implementation projects with local customers and R and amp;D partners, and to harness the world-class experience of the province in the delivery of healthcare services and ML (machine learning).
PROTXX CEO and Founder, John Ralston, added, “We are excited to announce our collaboration with AltaML. Clinical data sets collected over the past two years have revealed that the unique features and patterns detected in PROTXX wearable sensor data can be leveraged to independently classify and quantify multiple physiological impairments resulting from age-related disorders such as stroke, diseases such as Parkinson’s disease, injuries such as concussions and sub-concussive head impact exposure, and medical treatments such as prescription medications and invasive neurosurgeries. The application of state-of-the-art machine learning techniques for small data set classification and data visualization will accelerate our commercialization of innovative and scalable precision healthcare tools that improve the diagnoses and treatment of these and many other complex medical conditions.”
